Indonesia signs agreement with Sinovac for Covid-19 vaccine


Sinovac has granted priority access for bulk supply to Indonesia until the end of 2020. - Reuters

JAKARTA (Bloomberg): Indonesia signed an agreement with China's Sinovac Biotech for 50 million doses of Covid-19 vaccine concentrate that will allow state-owned PT Bio Farma to produce doses locally.

Sinovac will ship the concentrate in five equal stages between November and March, vaccine maker Bio Farma said in a statement on Saturday (Aug 22).

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Indonesia , Sinovac , covid-19 , vaccine , agreement

   

Next In Aseanplus News

Malaysia’s new wave chefs drive Kuala Lumpur’s culinary boom
Scientists in China use wax to make particles that can extract uranium from seawater
Plastic shopping bags turned into giant bear doll in Chiang Mai
Anxious China celebrity couple give short son hormone jabs to help him grow
Asean chairmanship in 2025 marks pivotal moment for Malaysia, say economists
It's Christmas time and Bursa Malaysia seen to be flat this week amid festive season
Ringgit expected to trade between 4.50 to 4.52 against the US dollar in narrow range amid Christmas holidays
Singapore watching four diseases including Covid-19 and mpox,as part of pandemic preparedness, says health minister
From Jungkook to Stray Kids, K-pop artistes stand strong in year-end charts
It's hot in South-East Asia - Philippines set up Thailand semi clash with Vietnam to face Singapore in Asean Championships

Others Also Read